Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting

Abstract

In this review, we aim to highlight the extent of inappropriate hemostasis testing and provide practical guidance on how to prevent it. We will focus on the acute setting, including but not limited to the emergency department and intensive care unit. To this end, we will first discuss the significance of inappropriateness, in the general context of laboratory medicine. This includes acknowledging the importance of the phenomenon and attempting to define it. Next, we describe the harmful consequences of inappropriate testing. Finally, we focus on the inappropriate use of hemostasis testing in the acute setting. The second section describes how interventions―in particular, the implementation of guidance for testing—can efficiently reduce inappropriateness. In the third section, we summarize the available recommendations for rational use of hemostasis testing (platelet count, activated partial thromboplastin time, prothrombin time/international normalized ratio, fibrinogen, thrombin time, D-dimer, anti-Xa assay, antithrombin, ADAMTS13 activity, antiheparin-PF4 antibodies, viscoelastometric tests, coagulation factors, and platelet function testing), as supported by guidelines, recommendations, and/or expert opinions. Overall, this review is intended to be a toolkit in the effort to promote the appropriate use of hemostasis testing. Hopefully, the new In Vitro Diagnostic Medical Device Regulation (EU) 2017/746 (IVDR) should help in improving the availability of evidence regarding clinical performance of hemostasis assays.

Keywords

laboratory tests - inappropriate - coagulation - demand management - IVDR

Authors' Contribution

L.D. and F.M. contributed to the design of the manuscript. L.D. and F.M. drafted the manuscript and tables. D.J.A., M.H., A.M., E.C., M.C., I.G-T., C.F., T.L., L.A., J.C., G.L., and F.M. substantially revised and enhanced the manuscript. All authors approved the final version of the manuscript.

Publikationsverlauf

Eingereicht: 17. Oktober 2024

Angenommen: 02. Dezember 2024

Artikel online veröffentlicht:
19. Februar 2025

• References

• 1 Lippi G. The irreplaceable value of laboratory diagnostics: four recent tests that have revolutionized clinical practice. EJIFCC 2019; 30 (01) 7-13
• 2 Mrazek C, Simundic AM, Salinas M. et al. Inappropriate use of laboratory tests: how availability triggers demand - examples across Europe. Clin Chim Acta 2020; 505: 100-107
• 3 VanSpronsen AD, Zychla L, Turley E, Villatoro V, Yuan Y, Ohinmaa A. Causes of inappropriate laboratory test ordering from the perspective of medical laboratory technical professionals: implications for research and education. Lab Med 2023; 54 (01) e18-e23
• 4 Vrijsen BEL, Naaktgeboren CA, Vos LM, van Solinge WW, Kaasjager HAH, Ten Berg MJ. Inappropriate laboratory testing in internal medicine inpatients: prevalence, causes and interventions. Ann Med Surg (Lond) 2020; 51: 48-53
• 5 Lippi G, Bovo C, Ciaccio M. Inappropriateness in laboratory medicine: an elephant in the room?. Ann Transl Med 2017; 5 (04) 82
• 6 Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One 2013; 8 (11) e78962
• 7 Cadamuro J, Gaksch M, Wiedemann H. et al. Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting. Clin Biochem 2018; 54: 85-91
• 8 Mansour A, Flecher E, Schmidt M. et al; ECMOSARS Investigators. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study. Intensive Care Med 2022; 48 (08) 1039-1052
• 9 Devis L, Catry E, Honore PM. et al. Interventions to improve appropriateness of laboratory testing in the intensive care unit: a narrative review. Ann Intensive Care 2024; 14 (01) 9
• 10 Lippi G, Favaloro EJ. Exploring the iceberg of inappropriateness in hemostasis testing. Diagnosis (Berl) 2017; 4 (01) 1-2
• 11 Pennestrì F, Banfi G. Value-based healthcare: the role of laboratory medicine. Clin Chem Lab Med 2019; 57 (06) 798-801
• 12 Plebani M, Cadamuro J, Vermeersch P. et al. A vision to the future: value-based laboratory medicine. Clin Chem Lab Med 2024; 62 (12) 2373-2387
• 13 Institute of Medicine, Council on Health Care Technology. Assessment of Diagnostic Technology in Health Care: Rationale, Methods, Problems, and Directions. National Academies Press; 1989
• 14 Lundberg GD. The need for an outcomes research agenda for clinical laboratory testing. JAMA 1998; 280 (06) 565-566
• 15 Devis L, Closset M, Degosserie J. et al. Revisiting the environmental impact of inappropriate clinical laboratory testing: a comprehensive overview of sustainability, economic, and quality of care outcomes. J Appl Lab Med 2024; jfae087
• 16 Spoyalo K, Lalande A, Rizan C. et al. Patient, hospital and environmental costs of unnecessary bloodwork: capturing the triple bottom line of inappropriate care in general surgery patients. BMJ Open Qual 2023; 12 (03) e002316
• 17 Sarkar MK, Botz CM, Laposata M. An assessment of overutilization and underutilization of laboratory tests by expert physicians in the evaluation of patients for bleeding and thrombotic disorders in clinical context and in real time. Diagnosis (Berl) 2017; 4 (01) 21-26
• 18 Cadamuro J, Simundic AM, von Meyer A. et al. Diagnostic workup of microcytic anemia: an evaluation of underuse or misuse of laboratory testing in a hospital setting using the AlinIQ system. Arch Pathol Lab Med 2023; 147 (01) 117-124
• 19 Koch CG, Li L, Sun Z. et al. Hospital-acquired anemia: prevalence, outcomes, and healthcare implications. J Hosp Med 2013; 8 (09) 506-512
• 20 Bodley T, Chan M, Levi O. et al. Patient harm associated with serial phlebotomy and blood waste in the intensive care unit: a retrospective cohort study. PLoS One 2021; 16 (01) e0243782
• 21 Helmer P, Hottenrott S, Steinisch A. et al. Avoidable blood loss in critical care and patient blood management: scoping review of diagnostic blood loss. J Clin Med 2022; 11 (02) 320
• 22 Siegal DM, Belley-Côté EP, Lee SF. et al. Small-volume blood collection tubes to reduce transfusions in intensive care: the STRATUS randomized clinical trial. JAMA 2023; 330 (19) 1872-1881
• 23 Lippi G, Plebani M. Laboratory “incidentalomas”: facts or fiction?. Eur J Intern Med 2010; 21 (06) 572
• 24 Pilowsky JK, Lane K, Learmonth G. et al; APTIC Investigators. Environmental impact of a blood test reduction intervention in adult intensive care units: a before and after quality improvement project. Aust Crit Care 2024; 37 (05) 761-766
• 25 The economics of diagnostic safety. OECD. September 17, 2024. Accessed October 5, 2024 at: https://www.oecd.org/en/publications/2024/09/the-economics-of-diagnostic-safety_2056205e.html
• 26 Thachil J, Lippi G, Favaloro EJ. D-dimer testing: laboratory aspects and current issues. Methods Mol Biol 2017; 1646: 91-104
• 27 Gonzaga Y, De Alencar JN. Advocating prudent D-dimer testing: constructive perspectives and comments on ‘How we manage a high D-dimer’. Haematologica 2024; 109 (10) 3452-3453
• 28 Devreese KMJ, de Groot PG, de Laat B. et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 2020; 18 (11) 2828-2839
• 29 Manning JE, Arachchillage DJ. Dilemmas in the diagnosis and management of antiphospholipid syndrome. J Thromb Haemost 2024; 22 (08) 2156-2170
• 30 Schouwers SME, Delanghe JR, Devreese KMJ. Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?. Thromb Res 2010; 125 (01) 102-104
• 31 Smart D, Schreier J, Singh IR. Inappropriate laboratory testing: significant waste quantified by a large-scale year-long study of Medicare and commercial payer reimbursement. Arch Pathol Lab Med 2024;
• 32 Virparia R, Brunetti L, Vigdor S, Adams CD. Appropriateness of thrombophilia testing in patients in the acute care setting and an evaluation of the associated costs. J Thromb Thrombolysis 2020; 49 (01) 108-112
• 33 Breth-Petersen M, Bell K, Pickles K, McGain F, McAlister S, Barratt A. Health, financial and environmental impacts of unnecessary vitamin D testing: a triple bottom line assessment adapted for healthcare. BMJ Open 2022; 12 (08) e056997
• 34 Lippi G, Daves M. Estimating the environmental impact of inappropriate laboratory testing. J Lab Precis Med 2017; 2: 52
• 35 McAlister S, Barratt AL, Bell KJ, McGain F. The carbon footprint of pathology testing. Med J Aust 2020; 212 (08) 377-382
• 36 Lang TF. Inappropriate laboratory testing: the hidden cost to the environment—time for a database of associated costs. J Appl Lab Med 2024; 9 (05) 1070-1072
• 37 Rabin AS, Lai PS, Maximous SI, Shankar HM. Reducing the climate impact of critical care. CHEST Crit Care 2024; 2 (01) 100037
• 38 Ostermann M, De Waele JJ, Schefold JC. The environmental impact of laboratory measurements in high-resource ICUs. Intensive Care Med 2024; 50 (03) 449-452
• 39 Pennestrì F, Tomaiuolo R, Banfi G, Dolci A. Blood over-testing: impact, ethical issues and mitigating actions. Clin Chem Lab Med 2024; 62 (07) 1283-1287
• 40 Oakman G, Anderson A, Oosthuizen JW, Olaussen A. Pathology requesting in a regional Australian Emergency Department; an observational study comparing current practice with college guidelines. Aust J Rural Health 2024; 32 (05) 1062-1067
• 41 Tientadakul P, Chinthammitr Y, Sanpakit K, Wongwanit C, Nilanont Y. Inappropriate use of protein C, protein S, and antithrombin testing for hereditary thrombophilia screening: an experience from a large university hospital. Int J Lab Hematol 2011; 33 (06) 593-600
• 42 Cuker A, Arepally GM, Chong BH. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2018; 2 (22) 3360-3392
• 43 Jindal V, Singh A, Siddiqui AD, Leb L. The appropriateness of testing platelet factor 4/heparin antibody in patients suspected of heparin-induced thrombocytopenia. Cureus 2018; 10 (10) e3532
• 44 Beauverd Y, Boehlen F, Tessitore E. et al. Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing?. Platelets 2015; 26 (07) 632-637
• 45 Crowther M, Cook D, Guyatt G. et al; PROTECT collaborators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. J Crit Care 2014; 29 (03) 470.e7-470.e15
• 46 Oliver M, Karkhaneh M, Karathra J, Goubran M, Wu CM. A review of inappropriate D-dimer ordering at a Canadian tertiary care centre. Blood 2019; 134 (Suppl. 01) 5778
• 47 Jones P, Elangbam B, Williams NR. Inappropriate use and interpretation of D-dimer testing in the emergency department: an unexpected adverse effect of meeting the “4-h target”. Emerg Med J 2010; 27 (01) 43-47
• 48 Franchini M, Focosi D, Pezzo MP, Mannucci PM. Response to the comment: "Advocating prudent D-dimer testing: constructive perspectives and comments on “How we manage a high D-dimer”. Haematologica 2024; 109 (10) 3454
• 49 Thonon H, Van Nieuwenhove M, Thachil J, Lippi G, Hardy M, Mullier F. Hemostasis testing in the emergency department: a narrative review. Semin Thromb Hemost 2024;
• 50 Mansour A, Berahou M, Odot J. et al. Antithrombin levels and heparin responsiveness during venoarterial extracorporeal membrane oxygenation: a prospective single-center cohort study. Anesthesiology 2024; 140 (06) 1153-1164
• 51 Mrazek C, Haschke-Becher E, Felder TK, Keppel MH, Oberkofler H, Cadamuro J. Laboratory demand management strategies-an overview. Diagnostics (Basel) 2021; 11 (07) 1141
• 52 Cadamuro J, Ibarz M, Cornes M. et al. Managing inappropriate utilization of laboratory resources. Diagnosis (Berl) 2019; 6 (01) 5-13
• 53 Bindraban RS, Ten Berg MJ, Naaktgeboren CA, Kramer MHH, Van Solinge WW, Nanayakkara PWB. Reducing test utilization in hospital settings: a narrative review. Ann Lab Med 2018; 38 (05) 402-412
• 54 Fryer AA, Smellie WSA. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol 2013; 66 (01) 62-72
• 55 Smellie WSA. Demand management and test request rationalization. Ann Clin Biochem 2012; 49 (Pt 4): 323-336
• 56 Ezzie ME, Aberegg SK, O'Brien Jr JM. Laboratory testing in the intensive care unit. Crit Care Clin 2007; 23 (03) 435-465
• 57 Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. JAMA 1998; 280 (23) 2020-2027
• 58 Yeshoua B, Bowman C, Dullea J. et al. Interventions to reduce repetitive ordering of low-value inpatient laboratory tests: a systematic review. BMJ Open Qual 2023; 12 (01) e002128
• 59 Lillo S, Larsen TR, Pennerup L, Antonsen S. The impact of interventions applied in primary care to optimize the use of laboratory tests: a systematic review. Clin Chem Lab Med 2021; 59 (08) 1336-1352
• 60 Ferraro S, Panteghini M. The role of laboratory in ensuring appropriate test requests. Clin Biochem 2017; 50 (10-11): 555-561
• 61 Panteghini M, Dolci A, Birindelli S, Szoke D, Aloisio E, Caruso S. Pursuing appropriateness of laboratory tests: a 15-year experience in an academic medical institution. Clin Chem Lab Med 2022; 60 (11) 1706-1718
• 62 Hooper KP, Anstey MH, Litton E. Safety and efficacy of routine diagnostic test reduction interventions in patients admitted to the intensive care unit: a systematic review and meta-analysis. Anaesth Intensive Care 2021; 49 (01) 23-34
• 63 Musca S, Desai S, Roberts B, Paterson T, Anstey M. Routine coagulation testing in intensive care. Crit Care Resusc 2016; 18 (03) 213-217
• 64 Cadamuro J, Mrazek C, Wiedemann H. et al. Effectiveness of a laboratory gate-keeping strategy to overcome inappropriate test utilization for the diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost 2017; 43 (06) 645-648
• 65 Gallo T, Curry SC, Heise CW, Antonescu CC, Raschke RA. Clinical decision support to reduce unnecessary diagnostic testing for heparin-induced thrombocytopenia. Br J Haematol 2023; 202 (05) 1011-1017
• 66 Zon RL, Sylvester KW, Rubins D. et al. Electronic alerts to improve management of heparin-induced thrombocytopenia. Res Pract Thromb Haemost 2024; 8 (04) 102423
• 67 Cogan JC, McFarland MM, May JE, Lim MY. Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review. Res Pract Thromb Haemost 2023; 7 (07) 102219
• 68 Thomas L, Woon E, Fong E, Parnaby C, Watson HG. Reducing the use of inappropriate coagulation testing in emergency general surgical patients. Scott Med J 2018; 63 (02) 45-50
• 69 Chee YL, Crawford JC, Watson HG, Greaves M. British Committee for Standards in Haematology. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. Br J Haematol 2008; 140 (05) 496-504
• 70 Lester W, Bent C, Alikhan R. et al; BSH Committee. A British Society for Haematology guideline on the assessment and management of bleeding risk prior to invasive procedures. Br J Haematol 2024; 204 (05) 1697-1713
• 71 Tawadrous D, Detombe S, Thompson D, Columbus M, Van Aarsen K, Skoretz T. Reducing unnecessary testing in the emergency department: the case for INR and aPTT. CJEM 2020; 22 (04) 534-541
• 72 Murphy E, MacGlone S, McGroarty C. A novel approach to improving coagulation sample ordering in an emergency department. BMJ Qual Improv Rep 2015; 4 (01) 204785
• 73 Kalsi MS, Foo CT, Farzanehfar P, Ayoub S, Tacey M, Pearson K. Interventions to support Choosing Wisely for coagulation studies in the emergency department. Emerg Med Australas 2020; 32 (06) 1071-1073
• 74 Callum J, Putowski Z, Alhazzani W. et al. Small-volume blood sample collection tubes in adult intensive care units: a rapid practice guideline. Acta Anaesthesiol Scand 2024; 68 (10) 1319-1326
• 75 Baird GS. The Choosing Wisely initiative and laboratory test stewardship. Diagnosis (Berl) 2019; 6 (01) 15-23
• 76 Lippi G, Mattiuzzi C. The biomarker paradigm: between diagnostic efficiency and clinical efficacy. Pol Arch Intern Med 2015; 125 (04) 282-288
• 77 Mullier F, Closset M, Devis L, Honore PM. Which strategies should we use to reduce inappropriate use of laboratory resources in the ICU: guidelines are urgently needed!. Crit Care Med 2024; 52 (06) e327-e328
• 78 Kumwilaisak K, Noto A, Schmidt UH. et al. Effect of laboratory testing guidelines on the utilization of tests and order entries in a surgical intensive care unit. Crit Care Med 2008; 36 (11) 2993-2999
• 79 Dhanani JA, Barnett AG, Lipman J, Reade MC. Strategies to reduce inappropriate laboratory blood test orders in intensive care are effective and safe: a before-and-after quality improvement study. Anaesth Intensive Care 2018; 46 (03) 313-320
• 80 Kotecha N, Shapiro JM, Cardasis J, Narayanswami G. Reducing unnecessary laboratory testing in the medical ICU. Am J Med 2017; 130 (06) 648-651
• 81 Prat G, Lefèvre M, Nowak E. et al. Impact of clinical guidelines to improve appropriateness of laboratory tests and chest radiographs. Intensive Care Med 2009; 35 (06) 1047-1053
• 82 Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA. et al. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: a single-center cross-sectional study. Thromb Res 2023; 223: 87-94
• 83 Tagariello G, Radossi P, Salviato R. et al. Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures. Blood Transfus 2017; 15 (06) 557-561
• 84 Bang HI, Lee JY, Kim HY. et al. Coagulation testing in real-world setting: Insights from a comprehensive survey. Clin Appl Thromb Hemost 2024; 30: 10 760296241228239
• 85 Anderson Z, Ahsan M, Aguirre C, Ramirez M, Plowman K. Inpatient thrombophilia workup; does hematology consult prevent unnecessary testing?. J Investig Med 2024; 72 (04) 392-395
• 86 Middeldorp S, Nieuwlaat R, Baumann Kreuziger L. et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv 2023; 7 (22) 7101-7138
• 87 Misra S, Moberg-Aakre K, Langlois M. et al. How useful are laboratory practice guidelines?. EJIFCC 2015; 26 (03) 190-196
• 88 Wang T, Tan JB, Liu XL, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ Open 2023; 13 (01) e062158
• 89 Fan BE, Lippi G, Favaloro EJ. D-dimer levels for the exclusion of pulmonary embolism: making sense of international guideline recommendations. J Thromb Haemost 2024; 22 (03) 604-608
• 90 Beloeil H, Ruchard D, Drewniak N, Molliex S. Overuse of preoperative laboratory coagulation testing and ABO blood typing: a French national study. Br J Anaesth 2017; 119 (06) 1186-1193
• 91 Islam MM, Poly TN, Yang HC, Li YJ. Deep into laboratory: an artificial intelligence approach to recommend laboratory tests. Diagnostics (Basel) 2021; 11 (06) 990
• 92 Cismondi F, Celi LA, Fialho AS. et al. Reducing unnecessary lab testing in the ICU with artificial intelligence. Int J Med Inform 2013; 82 (05) 345-358
• 93 Flores E, Martínez-Racaj L, Torreblanca R. et al. Clinical decision support system in laboratory medicine. Clin Chem Lab Med 2023; 62 (07) 1277-1282
• 94 Lee J, Maslove DM. Using information theory to identify redundancy in common laboratory tests in the intensive care unit. BMC Med Inform Decis Mak 2015; 15 (01) 59
• 95 Yu L, Li L, Bernstam E, Jiang X. A deep learning solution to recommend laboratory reduction strategies in ICU. Int J Med Inform 2020; 144 (104282): 104282
• 96 Fang K, Dong Z, Chen X. et al. Using machine learning to identify clotted specimens in coagulation testing. Clin Chem Lab Med 2021; 59 (07) 1289-1297
• 97 Padoan A, Cadamuro J, Frans G. et al. Data flow in clinical laboratories: could metadata and peridata bridge the gap to new AI-based applications?. Clin Chem Lab Med 2024;
• 98 Cadamuro J, Cabitza F, Debeljak Z. et al. Potentials and pitfalls of ChatGPT and natural-language artificial intelligence models for the understanding of laboratory medicine test results. An assessment by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Artificial Intelligence (WG-AI). Clin Chem Lab Med 2023; 61 (07) 1158-1166
• 99 Ibarz M, Cadamuro J, Sumarac Z. et al. Clinicians' and laboratory medicine specialists' views on laboratory demand management: a survey in nine European countries. Diagnosis (Berl) 2020; 8 (01) 111-119
• 100 Testa S, Meijer P, Lasne D, Mullier F. Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: guidance is urgently required for haemostasis testing. Int J Lab Hematol 2022; 44 (1, Suppl 1): 71-78
• 101 Lang T. Minimum retesting intervals in practice: 10 years experience. Clin Chem Lab Med 2020; 59 (01) 39-50
• 102 Lippi G, Brambilla M, Bonelli P. et al. Effectiveness of a computerized alert system based on re-testing intervals for limiting the inappropriateness of laboratory test requests. Clin Biochem 2015; 48 (16-17): 1174-1176
• 103 McPhedran P, Clyne LP, Ortoli NA, Gagnon PG, Sanders FJ. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic. Am J Clin Pathol 1974; 62 (01) 16-20
• 104 Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis 2010; 21 (05) 459-463
• 105 Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996; 9 (02) 331-354
• 106 Chu K, Wu SM, Stanley T, Stafford DW, High KA. A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism. J Clin Invest 1996; 98 (07) 1619-1625
• 107 Oldenburg J, Quenzel EM, Harbrecht U. et al. Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. Br J Haematol 1997; 98 (01) 240-244
• 108 Tripodi A, Cohen H, Devreese KMJ. Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2020; 18 (07) 1569-1575
• 109 Dufrost V, Risse J, Reshetnyak T. et al. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. Autoimmun Rev 2018; 17 (10) 1011-1021
• 110 Zuily S, Cohen H, Isenberg D. et al. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2020; 18 (09) 2126-2137
• 111 Lisman T, Bongers TN, Adelmeijer J. et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44 (01) 53-61
• 112 Tripodi A, Salerno F, Chantarangkul V. et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41 (03) 553-558
• 113 Lisman T, Hernandez-Gea V, Magnusson M. et al. The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease. J Thromb Haemost 2021; 19 (04) 1116-1122
• 114 Northup PG, Garcia-Pagan JC, Garcia-Tsao G. et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 73 (01) 366-413
• 115 European Association for the Study of the Liver. Electronic address: [e-mail], European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol 2022; 76 (05) 1151-1184
• 116 Rautou PE, Caldwell SH, Villa E. Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-art appraisal. Clin Gastroenterol Hepatol 2023; 21 (08) 2110-2123
• 117 Lisman T, Procopet B. Fresh frozen plasma in treating acute variceal bleeding: not effective and likely harmful. Liver Int 2021; 41 (08) 1710-1712
• 118 Zanetto A, Northup P, Roberts L, Senzolo M. Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation. J Hepatol 2023; 78 (05) 1037-1047
• 119 Mansour A, Godier A, Lecompte T, Roullet S. Ten considerations about viscoelastometric tests. Anaesth Crit Care Pain Med 2024; 43 (03) 101366
• 120 Tripodi A, Primignani M, D'Ambrosio R. et al. Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis. Hepatology 2024;
• 121 Iba T, Levi M, Thachil J, Helms J, Scarlatescu E, Levy JH. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. J Thromb Haemost 2023; 21 (01) 145-153
• 122 Hardy M, Michaux I, Bulpa P. et al. Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: a prospective observational study. Thromb Res 2023; 221: 69-72
• 123 Gris JC, Cochery-Nouvellon E, Bouvier S. et al. Clinical value of automated fibrin generation markers in patients with septic shock: a SepsiCoag ancillary study. Br J Haematol 2018; 183 (04) 636-647
• 124 Singh N, Pati HP, Tyagi S, Upadhyay AD, Saxena R. Evaluation of the diagnostic performance of fibrin monomer in comparison to d-dimer in patients with overt and nonovert disseminated intravascular coagulation. Clin Appl Thromb Hemost 2017; 23 (05) 460-465
• 125 Bouarroudj HZ, Hardy M, Lecompte T, Mullier F. Preanalytical conditions impact fibrin monomers but not D-dimer: a study with rigorous comparisons of a broad range of simulated conditions. Int J Lab Hematol 2024;
• 126 Rossaint R, Afshari A, Bouillon B. et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care 2023; 27 (01) 80
• 127 Ranucci M, Baryshnikova E. Sensitivity of viscoelastic tests to platelet function. J Clin Med 2020; 9 (01) 189
• 128 Ajzenberg N, Longrois D, Faille D. et al. Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study. J Thromb Haemost 2024; 22 (11) 3048-3058
• 129 Middeldorp S, Iorio A. Thrombophilia testing: does practice follow guidelines?. Blood Adv 2024; 8 (18) 4948-4949
• 130 Djulbegovic B, Hozo I, Guyatt G. Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines. Blood Adv 2024; 8 (13) 3596-3606
• 131 Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol 2022; 198 (03) 443-458
• 132 O'Brien SH, Badawy SM, Rotz SJ. et al. The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatr Blood Cancer 2021; 68 (08) e28967
• 133 Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017; 377 (12) 1177-1187
• 134 Trillot N, Marlu R, Suchon P. et al. Prescribing and performing a biological assessment for thrombophilia: GFHT 2022 proposals Part I: Clinical aspects and prescription in classic venous thromboembolic disease. Revue Francophone d'Hémostase et Thrombose 2022; 4 (03) 133-152
• 135 Trillot N, Dargaud Y, Gruel Y, Morange P. Prescribing and performing a biological assessment for thrombophilia: GFHT 2022 proposals Part II: Prescribing in the case of atypical thrombosis and in special situations. Revue Francophone d'Hémostase et Thrombose 2022; 4 (04) 197-230
• 136 Alameddine R, Nassabein R, Le Gal G, Sié P, Mullier F, Blais N. Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants. Thromb Res 2020; 185: 72-77
• 137 Isert M, Miesbach W, Stoever G, Lindhoff-Last E, Linnemann B. Screening for lupus anticoagulants in patients treated with vitamin K antagonists. Int J Lab Hematol 2015; 37 (06) 758-765
• 138 Hardy M, Catry E, Pouplard M, Lecompte T, Mullier F. Is lupus anticoagulant testing with dilute Russell's viper venom clotting times reliable in the presence of inflammation?. Res Pract Thromb Haemost 2024; 8 (06) 102536
• 139 Favresse J, Lardinois B, Sabor L. et al. Evaluation of the DOAC-Stop® procedure to overcome the effect of DOACs on several thrombophilia screening tests. TH Open 2018; 2 (02) e202-e209
• 140 Favaloro EJ, Pasalic L, Selby R. Testing for the lupus anticoagulant: the good, the bad, and the ugly. Res Pract Thromb Haemost 2024; 8 (03) 102385
• 141 Slavik L, Jacova J, Friedecky D. et al. Evaluation of the DOAC-Stop procedure by LC-MS/MS assays for determining the residual activity of dabigatran, rivaroxaban, and apixaban. Clin Appl Thromb Hemost 2019; 25: 10 76029619872556
• 142 Kopatz WF, Brinkman HJM, Meijers JCM. Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay. Thromb Res 2018; 170: 97-101
• 143 Umemura Y, Yamakawa K, Hayakawa M, Hamasaki T, Fujimi S. Japan Septic Disseminated Intravascular Coagulation (J-Septic DIC) study group. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: a nationwide multicenter registry in Japan. Thromb Res 2018; 161: 60-66
• 144 Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M. Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 2019; 17 (11) 1989-1994
• 145 Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol 2017; 177 (01) 27-38
• 146 Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology (Am Soc Hematol Educ Program) 2010; 2010 (01) 135-143
• 147 Greinacher A. Clinical Practice. Heparin-induced thrombocytopenia. N Engl J Med 2015; 373 (03) 252-261
• 148 Gruel Y, De Maistre E, Pouplard C. et al; Members of the French Working Group on Perioperative Haemostasis Groupe D'intérêt en Hémostase Périopératoire GIHP. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med 2020; 39 (02) 291-310
• 149 Wada H, Thachil J, Di Nisio M. et al; The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; 11 (04) 761-767
• 150 Kietaibl S, Ahmed A, Afshari A. et al. Management of severe peri-operative bleeding: guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022. Eur J Anaesthesiol 2023; 40 (04) 226-304
• 151 Spahn DR, Bouillon B, Cerny V. et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care 2019; 23 (01) 98
• 152 Lippi G, Favaloro EJ, Buoro S. Platelet transfusion thresholds: How low can we go in respect to platelet counting?. Semin Thromb Hemost 2020; 46 (03) 238-244
• 153 Lippi G, Favaloro EJ, Franchini M. Dangers in the practice of defensive medicine in hemostasis testing for investigation of bleeding or thrombosis: Part I–routine coagulation testing. Semin Thromb Hemost 2014; 40 (07) 812-824
• 154 Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med 1993; 119 (09) 874-881
• 155 Smith ML, Wheeler KE. Weight-based heparin protocol using antifactor Xa monitoring. Am J Health Syst Pharm 2010; 67 (05) 371-374
• 156 Baker P, Platton S, Arachchillage DJ. et al; BSH Committee. Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays: a British Society for Haematology Guideline. Br J Haematol 2024; 205 (04) 1302-1318
• 157 Gouin-Thibault I, Mansour A, Hardy M. et al. Management of therapeutic-intensity unfractionated heparin: a narrative review on critical points. TH Open 2024; 8 (03) e297-e307
• 158 Levi M, Toh CH, Thachil J, Watson HG. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009; 145 (01) 24-33
• 159 Lee A. Emergency management of patients with bleeding disorders: practical points for the emergency physician. Transfus Apher Sci 2019; 58 (05) 553-562
• 160 Casini A, Al-Samkari H, Hayward C, Peyvandi F. Rare bleeding disorders: advances in management. Haemophilia 2024; 30 (Suppl. 03) 60-69
• 161 Kuramatsu JB, Gerner ST, Schellinger PD. et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 2015; 313 (08) 824-836
• 162 Schwebach AA, Waybright RA, Johnson TJ. Fixed-dose four-factor prothrombin complex concentrate for vitamin K antagonist reversal: Does one dose fit all?. Pharmacotherapy 2019; 39 (05) 599-608
• 163 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the early management of patients with Acute Ischemic Stroke: 2019 update to the 2018 guidelines for the early management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
• 164 Bonhomme F, Ajzenberg N, Schved JF, Molliex S, Samama CM. French Anaesthetic and Intensive Care Committee on Evaluation of Routine Preoperative Testing, French Society of Anaesthesia and Intensive Care. Pre-interventional haemostatic assessment: guidelines from the French Society of Anaesthesia and Intensive Care. Eur J Anaesthesiol 2013; 30 (04) 142-162
• 165 Thomas D, Wee M, Clyburn P. et al; Association of Anaesthetists of Great Britain and Ireland. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 2010; 65 (11) 1153-1161
• 166 Advisory panel guidance on minimum retesting intervals for lab tests: Appropriate use recommendation [internet]. Published online June 2024. Accessed August 20, 2024 at: https://pubmed.ncbi.nlm.nih.gov/39088670/
• 167 Pernod G, Godiér A, Gozalo C, Tremey B, Sié P. French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res 2010; 126 (03) e167-e174
• 168 Lawrence B, Siau K. Use of FFP to correct INR: time to drop this from the decompensated cirrhosis care bundle?. Frontline Gastroenterol 2022; 13 (05) 456
• 169 Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): Is there consensus?. Clin Chem Lab Med 2015; 53 (02) 185-197
• 170 Lessire S, Douxfils J, Baudar J. et al. Is thrombin time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study. Thromb Res 2015; 136 (03) 693-696
• 171 Wauthier L, Favresse J, Hardy M. et al. D-dimer testing: a narrative review. Adv Clin Chem 2023; 114: 151-223
• 172 Suzuki K, Wada H, Imai H, Iba T, Thachil J, Toh CH. Subcommittee on Disseminated Intravascular Coagulation. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16 (07) 1442-1444
• 173 Favaloro EJ, Franchini M, Lippi G. Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review. Semin Thromb Hemost 2014; 40 (06) 621-633
• 174 Gouin-Thibault I, Pautas E, Siguret V. Safety profile of different low-molecular weight heparins used at therapeutic dose. Drug Saf 2005; 28 (04) 333-349
• 175 Douxfils J, Ageno W, Samama CM. et al. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost 2018; 16 (02) 209-219
• 176 Levy JH, Shaw JR, Castellucci LA. et al. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost 2024; 22 (10) 2889-2899
• 177 Berge E, Whiteley W, Audebert H. et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 2021; 6 (01) I-LXII
• 178 Knot EA, de Jong E, ten Cate JW, Gie LK, van Royen EA. Antithrombin III: biodistribution in healthy volunteers. Thromb Haemost 1987; 58 (04) 1008-1011
• 179 Wada H, Takahashi H, Uchiyama T. et al; DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis. The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J 2017; 15 (01) 17
• 180 Gouin-Thibault I, Mullier F, Lecompte T. “Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Gouin-Thibault et al. J Thromb Haemost 2024; 22 (02) 572-574
• 181 Helms J, Frere C, Thiele T. et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2023; 21 (02) 373-396
• 182 Van Cott EM, Orlando C, Moore GW, Cooper PC, Meijer P, Marlar R. Subcommittee on Plasma Coagulation Inhibitors. Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH. J Thromb Haemost 2020; 18 (01) 17-22
• 183 Levy JH, Frere C, Koster A. Resistance to unfractionated heparin in the ICU: evaluation and management options. Intensive Care Med 2023; 49 (08) 1005-1007
• 184 McMichael ABV, Ryerson LM, Ratano D, Fan E, Faraoni D, Annich GM. 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO J 2022; 68 (03) 303-310
• 185 Taylor A, Vendramin C, Oosterholt S, Della Pasqua O, Scully M. Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura. J Thromb Haemost 2019; 17 (01) 88-98
• 186 Scully M, Rayment R, Clark A. et al; BSH Committee. A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. Br J Haematol 2023; 203 (04) 546-563
• 187 Zheng XL, Vesely SK, Cataland SR. et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 2020; 18 (10) 2486-2495
• 188 Graça NAG, Joly BS, Voorberg J. et al. TTP: from empiricism for an enigmatic disease to targeted molecular therapies. Br J Haematol 2022; 197 (02) 156-170
• 189 Coppo P, Cuker A, George JN. Thrombotic thrombocytopenic purpura: toward targeted therapy and precision medicine. Res Pract Thromb Haemost 2018; 3 (01) 26-37
• 190 Marchetti M, Barelli S, Zermatten MG. et al. Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia. Blood 2020; 135 (14) 1171-1184
• 191 Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344 (17) 1286-1292
• 192 Linkins LA, Bates SM, Lee AYY, Heddle NM, Wang G, Warkentin TE. Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study. Blood 2015; 126 (05) 597-603
• 193 Arachchillage DJ, Thachil J, Anderson JAM. et al; BSH Committee. Diagnosis and management of heparin-induced thrombocytopenia: third edition. Br J Haematol 2024; 204 (02) 459-475
• 194 Gall LS, Brohi K, Davenport RA. Diagnosis and treatment of hyperfibrinolysis in trauma (a European perspective). Semin Thromb Hemost 2017; 43 (02) 224-234
• 195 Walsh M, Shreve J, Thomas S. et al. Fibrinolysis in trauma: “Myth,” “Reality,” or “something in between”. Semin Thromb Hemost 2017; 43 (02) 200-212
• 196 Raza I, Davenport R, Rourke C. et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11 (02) 307-314
• 197 Gall LS, Davenport RA. Fibrinolysis and antifibrinolytic treatment in the trauma patient. Curr Opin Anaesthesiol 2018; 31 (02) 227-233
• 198 Bareille M, Lecompte T, Mullier F, Roullet S. Are viscoelastometric assays of old generation ready for disposal? Comment on Volod et al. Viscoelastic hemostatic assays: a primer on legacy and new generation devices. J Clin Med 2023; 12 (02) 477
• 199 Hartmann J, Hermelin D, Levy JH. Viscoelastic testing: an illustrated review of technology and clinical applications. Res Pract Thromb Haemost 2022; 7 (01) 100031
• 200 Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104 (05) 1243-1252
• 201 Müller PC, Kabacam G, Vibert E, Germani G, Petrowsky H. Current status of liver transplantation in Europe. Int J Surg 2020; 82S: 22-29
• 202 Goel A, Lalruatsanga D, Himanshu D, Bharti V, Sharma D. Acute liver failure prognostic criteria: it's time to revisit. Cureus 2023; 15 (01) e33810
• 203 Frelinger III AL, Gachet C, Mumford AD. et al; Subcommittee on Platelet Physiology. Laboratory monitoring of P2Y₁₂ inhibitors: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16 (11) 2341-2346
• 204 Godier A, Garrigue D, Lasne D. et al; French Working Group on Perioperative Haemostasis (GIHP). Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR). Arch Cardiovasc Dis 2019; 112 (03) 199-216
• 205 Valgimigli M, Bueno H, Byrne RA. et al; ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39 (03) 213-260
• 206 Ferraris VA, Saha SP, Oestreich JH. et al; Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012; 94 (05) 1761-1781
• 207 Asakura H, Takahashi H, Uchiyama T. et al; DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J 2016; 14 (01) 42
• 208 Di Nisio M, Baudo F, Cosmi B. et al; Italian Society for Thrombosis and Haemostasis. Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2012; 129 (05) e177-e184
• 209 Aota T, Wada H, Fujimoto N. et al. Evaluation of the diagnostic criteria for the basic type of DIC established by the Japanese Society of Thrombosis and Hemostasis. Clin Appl Thromb Hemost 2017; 23 (07) 838-843
• 210 Azoulay E, Bauer PR, Mariotte E. et al; Nine-I Investigators. Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 2019; 45 (11) 1518-1539
• 211 Coppo P. French Reference Center for Thrombotic Microangiopathies. Management of thrombotic thrombocytopenic purpura. Transfus Clin Biol 2017; 24 (03) 148-153